Delivery Order SPE2DB24D8002-SPE2DB25FJNDK
Award Date
2/12/25
Potential Completion Date
2/13/25
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $5,346.71, is for the delivery of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product, with a period of performance through January 15, 2025. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, providing a comprehensive range of pharmaceutical products, medical supplies, and...
This federal contract award, valued at $2,698.33, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a delivery order for Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product, with a performance period ending on March 8, 2024. Dakota Drug, Inc. is a key supplier to the DLA's Troop Support Medical division, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) as part of the DLA Troop Support...
This is a $6,331.52 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product, with a performance period ending on January 15, 2025. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the ECAT Generation V Program, which allows the company to...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business that specializes in providing pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal government. The contract, valued at $7,225.70, is a firm fixed-price delivery order for the supply of Fluticasone-Salmeterol 115-21 12GM inhalers. The award is associated with a larger Indefinite Delivery Contract (IDC) between Dakota...
This federal contract award, valued at $4,206.61, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of 4566601984 units of the pharmaceutical product Fluticasone-Salmeterol 115-21 12GM, a respiratory medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The contract has a firm fixed-price delivery order structure and an ultimate completion date of December 4, 2024....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $3,476.84, is for the delivery of Fluticasone-Salmeterol 45-21 12GM, a pharmaceutical product. The contract does not have a set-aside designation and is set to be completed by October 29, 2024. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, providing a range of pharmaceutical...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $4,693.47 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide FLUTICASONE-SALMETEROL 230-21 12GM. This contract is part of Dakota Drug's larger $999,999,999.00 Indefinite Delivery Contract (IDC) under the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment, accessories, consumables, and medical simulation equipment....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $1,128.03 contract is for the delivery of Fluticasone-Salmeterol 500-50 60s, a pharmaceutical product used to treat respiratory conditions. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with DLA Troop Support Medical's ECAT...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of the pharmaceutical product "FLUTICASONE-SALMETEROL 115-21 12GM". The contract has a potential value of $11,906.17 and a completion date of February 21, 2024. Dakota Drug, Inc. is an experienced federal contractor, having served as a prime to the DLA Troop Support Medical for over two...
This federal contract award, SPE2DB24D8003|SPE2DB25FJTNP, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of fluticasone-salmeterol 230-21 12GM pharmaceutical products. The award has a ceiling value of $9,501.67 and is a Firm Fixed Price delivery order contract with a period of performance through December 31, 2024. This award is not associated with a set-aside program. Dakota Drug, Inc. is...